
Auteur P. VICKERMAN
|
Documents disponibles écrits par cet auteur (44)

Nouveauté
J. M. KESTEN ; R. AYRES ; J. NEALE ; J. CLARK ; P. VICKERMAN ; M. HICKMAN ; S. REDWOOD | 2017
Dans International Journal of Drug Policy (Vol.39, January 2017) Article : PériodiqueBackground: It is recommended that needle and syringe programmes (NSP) distribute low dead space syringes (LDSS) to reduce blood-borne virus transmission. We explored the acceptability of detachable LDSS among people who inject drugs (PWID) and [...]
L. A. HINES ; A. TRICKEY ; J. LEUNG ; S. LARNEY ; A. PEACOCK ; L. DEGENHARDT ; S. COLLEDGE ; M. HICKMAN ; J. GREBELY ; E. B. CUNNINGHAM ; J. STONE ; K. DUMCHEV ; P. GRIFFITHS ; P. VICKERMAN ; R. P. MATTICK ; M. LYNSKEY | 2020
Dans Lancet Global Health (The) (Vol.8, n°1, January 2020) Article : PériodiqueBACKGROUND: Globally, an estimated 15.6 million people inject drugs. We aimed to investigate global variation in the age profile of people who inject drugs (PWID), identify country-level factors associated with age of PWID, and assess the associ[...]
P. VICKERMAN ; N. MARTIN ; K. TURNER ; M. HICKMAN | 2012
Dans Addiction (Vol.107, n°11, November 2012) Article : PériodiqueAims: To investigate the impact of scaling-up opiate substitution therapy (OST) and high coverage needle and syringe programmes (100%NSP - obtaining more sterile syringes than you inject) on HCV prevalence among injecting drug users (IDUs). De[...]
N. K. MARTIN ; M. HICKMAN ; S. J. HUTCHINSON ; D. J. GOLDBERG ; P. VICKERMAN | 2013
Dans Clinical Infectious Diseases (Vol.57, Suppl.2, August 2013) Article : PériodiqueBACKGROUND: Interventions such as opiate substitution therapy (OST) and high-coverage needle and syringe programs (HCNSP) cannot substantially reduce hepatitis C virus (HCV) prevalence among people who inject drugs (PWID). HCV antiviral treatmen[...]
P. VICKERMAN ; N. K. MARTIN ; M. HICKMAN | 2013
Dans International Journal of Drug Policy (Vol.24, n°1, January 2013) Article : PériodiqueStudies published by Zule and colleagues have suggested that use of low dead-space syringes (LDSS) instead of high dead-space syringes (HDSS) by injecting drug users (IDUs) could dramatically reduce HIV transmission. However, evidence is limited[...]
E. HANCOCK ; Z. WARD ; R. AYRES ; J. NEALE ; D. HUSSEY ; J. M. KESTEN ; M. HICKMAN ; P. VICKERMAN | 2020
Dans Addiction (Vol.115, n°4, April 2020) Article : PériodiqueBACKGROUND AND AIMS: Traditional detachable syringes used by people who inject drugs (PWID) retain larger volumes of blood when the plunger is depressed than syringes with fixed needles-referred to as high (HDSS) and low dead space syringes (LDS[...]
L. PLATT ; J. REED ; S. MINOZZI ; P. VICKERMAN ; H. HAGAN ; C. FRENCH ; A. JORDAN ; L. DEGENHARDT ; V. HOPE ; S. HUTCHINSON ; L. MAHER ; N. PALMATEER ; A. TAYLOR ; M. HICKMAN | 2016
Dans Cochrane Database of Systematic Reviews (n°1, 2016) Article : PériodiqueThis is the protocol for a review and there is no abstract. The objectives are as follows: 1. To assess the impact of needle/syringe programmes with and without opiate substitution therapy (OST) on the incidence of HCV infection among people w[...]
L. DEGENHARDT ; P. WEBB ; S. COLLEDGE-FRISBY ; J. IRELAND ; A. WHEELER ; S. OTTAVIANO ; A. WILLING ; A. KAIROUZ ; E. B. CUNNINGHAM ; B. HAJARIZADEH ; J. LEUNG ; L. T. TRAN ; O. PRICE ; A. PEACOCK ; P. VICKERMAN ; M. FARRELL ; G. J. DORE ; M. HICKMAN ; J. GREBELY | 2023
Dans Lancet Global Health (The) (Vol.11, n°5, May 2023) Article : PériodiqueBACKGROUND: People who inject drugs are exposed to various and changing risk environments and are at risk of multiple harms related to injecting drug use (IDU). We aimed to undertake a global systematic review of the prevalence of IDU, key IDU-r[...]
S. SWEENEY ; Z. WARD ; L. PLATT ; L. GUINNESS ; M. HICKMAN ; V. HOPE ; L. MAHER ; J. IVERSEN ; S. J. HUTCHINSON ; J. SMITH ; R. AYRES ; I. HAINEY ; P. VICKERMAN | 2019
Dans Addiction (Vol.114, n°3, March 2019) Article : PériodiqueAIM: To evaluate the cost-effectiveness of needle and syringe programmes (NSPs) compared with no NSPs on hepatitis C virus (HCV) transmission in the United Kingdom. DESIGN: Cost-effectiveness analysis from a National Health Service (NHS)/healt[...]
V. HOPE ; J. KIMBER ; P. VICKERMAN ; M. HICKMAN ; F. NCUBE | 2008
Dans BMC Infectious Diseases (Vol.8, n°120, 18 September 2008) Article : PériodiqueBACKGROUND: Injection site infections among injecting drug users (IDUs) have been associated with serious morbidity and health service costs in North America. This study explores the frequency, factors and costs associated with injection site in[...]
S. COLLEDGE ; J. LEUNG ; S. LARNEY ; A. PEACOCK ; J. GREBELY ; M. HICKMAN ; E. CUNNINGHAM ; A. TRICKEY ; J. STONE ; P. VICKERMAN ; L. DEGENHARDT | 2020
Dans International Journal of Drug Policy (Vol.76, February 2020) Article : PériodiqueBACKGROUND: People who inject drugs (PWID) do so at varying frequencies. More frequent injecting is associated with skin and soft tissue infection, blood borne viruses, and overdose. The aims of this review are to estimate the prevalence of inje[...]
S. COLLEDGE-FRISBY ; S. OTTAVIANO ; P. WEBB ; J. GREBELY ; A. WHEELER ; E. B. CUNNINGHAM ; B. HAJARIZADEH ; J. LEUNG ; A. PEACOCK ; P. VICKERMAN ; M. FARRELL ; G. J. DORE ; M. HICKMAN ; L. DEGENHARDT | 2023
Dans Lancet Global Health (The) (Vol.11, n°5, May 2023) Article : PériodiqueBACKGROUND: Harm reduction and treatment programmes are essential for reducing harms for people who inject drugs (PWID). We aimed to update estimates from a 2017 review of global coverage of needle and syringe exchange programmes (NSPs), opioid [...]
J. LEUNG ; A. PEACOCK ; S. COLLEDGE ; J. GREBELY ; E. B. CUNNINGHAM ; M. HICKMAN ; P. VICKERMAN ; J. STONE ; A. TRICKEY ; K. DUMCHEV ; M. LYNSKEY ; L. HINES ; P. GRIFFITHS ; R. P. MATTICK ; L. DEGENHARDT ; S. LARNEY | 2019
Dans Journal of Infectious Diseases (Vol.220, n°1, July 2019) Article : PériodiqueBACKGROUND: Women-specific factors exist that increases vulnerability to drug-related harms from injection drug use, including blood-borne viruses (BBVs), but gender-based differences in BBV prevalence have not been systematically examined. MET[...]
L. DEGENHARDT ; J. GREBELY ; J. STONE ; M. HICKMAN ; P. VICKERMAN ; B. D. L. MARSHALL ; J. BRUNEAU ; F. L. ALTICE ; G. HENDERSON ; A. RAHIMI-MOVAGHAR ; S. LARNEY | 2019
Dans Lancet (The) (Vol.394, n°10208, 26 October 2019) Article : PériodiqueWe summarise the evidence for medicinal uses of opioids, harms related to the extramedical use of, and dependence on, these drugs, and a wide range of interventions used to address these harms. The Global Burden of Diseases, Injuries, and Risk F[...]
L. DEGENHARDT ; A. PEACOCK ; S. COLLEDGE ; J. LEUNG ; J. GREBELY ; P. VICKERMAN ; J. STONE ; E. B. CUNNINGHAM ; A. TRICKEY ; K. DUMCHEV ; M. LYNSKEY ; P. GRIFFITHS ; R. P. MATTICK ; M. HICKMAN ; S. LARNEY | 2017
Dans Lancet Global Health (The) (Vol.5, n°12, December 2017) Article : PériodiqueBackground: Sharing of equipment used for injecting drug use (IDU) is a substantial cause of disease burden and a contributor to blood-borne virus transmission. We did a global multistage systematic review to identify the prevalence of IDU among[...]